Read + Share
Amedeo Smart
Independent Medical Education
Jen WY, Jabbour E, Short NJ, Issa GC, et al. A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. Am J Hematol 2024 Aug 28. doi: 10.1002/ajh.27463.PMID: 39194286
Email
LinkedIn
Privacy Policy